In other malignancies, such as gastric cancer and breast cancers, NOTCH receptor expression is a good prognostic indicator of residual disease, where low NOTCH2 expression in residual tumours is correlated with longer survival times [20]. This evidence concerns the gene NOTCH2 and gastric cancer.